Vimy Ridge Capital Holding takes 30% stake in Esox Biologics, an aquaculture biotech firm
Published
Vimy Ridge Capital Holding Inc. entered Esox Biologics’ register with 8,572 B ordinary shares, representing a 30% holding. The company’s total shares rose from 20,000 to 28,572 over the two-year period, suggesting fresh funding. The changes span a multi-year period, with the filing dated 21 September 2026 and covering 6 August 2024 to 6 August 2026.
Shareholder data
Source: Companies House confirmation statement (CS01) — period to , filed .
Changes in this confirmation statement
| Type | Shareholder | Shares | Change | Share classes |
|---|---|---|---|---|
| New shareholder | VIMY RIDGE CAPITAL HOLDING INC. | 8,572 | — | B ORDINARY 8,572 |
Current shareholders (1)
| Shareholder | Total shares | Share classes |
|---|---|---|
| VIMY RIDGE CAPITAL HOLDING INC. | 8,572 | B ORDINARY 8,572 |
Similar companies
Companies with the most similar business descriptions.
- Wellfish Tech LtdHealth Tech · Diagnostics · Aquaculture
- Metagenomic Solutions LimitedBioinformatics · Life Sciences
- Pharmaq Analytiq LimitedVeterinary · Diagnostics · Lab Tech
- Phenome Longevity LtdGenomics · Precision Medicine · Longevity
- Marinnovac Uk LimitedHealth Tech · Aquaculture · Diagnostics
- Geneomics Solutions LtdBioinformatics · Life Sciences · Data Analytics
More rounds like this
Contact the editorial team at editorial@fundingspotter.com